Navigation Links
BioLineRx Presents Phase I Clinical Data of BL-1020 at Upcoming,Clinical Conferences

forward-looking statements involve known and unknown risks and uncertainties that may cause the actual results, performance or achievements of BioLineRx to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements.

Contact

BioLineRx Ltd.
VP Finance and Corporate Development
Yuri Shoshan, +972-2-548-9100
yuri@biolinerx.com
Tsipi Haitovsky, +972-52-598-9892
Media Liaison
tsipih@biolinerx.com
or
Stern Investor Relations, Inc.
Melanie Friedman, 212-362-1200
melanie@sternir.com


'"/>




Page: 1 2 3

Related medicine technology :

1. BioLineRx Presents Data From Successful Phase I Trial for BL-1020 in Schizophrenia at American Psychiatric Association Conference
2. BioLineRx Presents Data on BL-1040 at Cardiovascular Revascularization Therapies Conference Demonstrating Potential to Reduce Deterioration of Infarcted Heart Tissue and Maintain Functionality
3. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
4. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
5. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
6. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
7. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
8. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis
9. BioLife Solutions Presents Data on CryoStor at International Society for Cellular Therapy Annual Meeting
10. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
11. Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its Ghrelin Antagonist Program at the American Diabetes Associations Annual Meeting

Post Your Comments:
(Date:11/25/2009)...,Fla., Nov.25/PRNewswire-FirstCall/--AmericanScie...ispleasedtoannouncethattheyhaveopenedaregionalmark.... ,, ASRhasbeenabletosecurealocationabroad,prov...ionofcurrentandfuturehealthandsafetyproductsforchi...ntlythecompanyhousesinventoryinthestateofOhiowhere...
(Date:11/25/2009)...TON,N.J.,Nov.25/PRNewswire-FirstCall/--Pharmasset,...mpanycommittedtodiscovering,developingandcommercia...ancialresultsforthefiscalyearendedSeptember30,2009...h,cashequivalentsandshortterminvestments. ,, P..., Phase2bTrial ,, InlateNovember2009,anind...
(Date:11/25/2009)...Pa.,Nov.25/PRNewswire/--BioTrendsResearchGroup,Inc... report,thefirstinamulti-phasesyndicatedmarketrese...h,sStelara,fromproductlaunchthroughthefirstsixmont...tativeinformationfrom75uniqueDermatologistsandqual...trialanduseofStelara,obstaclestouse,typicalpatient...
Breaking Medicine Technology:American Scientific Resources Inc. Opens Shanghai Location 2Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2NIMOTUZUMAB DEMONSTRATES EFFICACY IN RANDOMIZED HEAD 26 NECK CANCER STUDY WITHOUT THE TOXICITIES ASSOCIATED WITH OTHER EGFR DRUGS 12377 1NIMOTUZUMAB DEMONSTRATES EFFICACY IN RANDOMIZED HEAD 26 NECK CANCER STUDY WITHOUT THE TOXICITIES ASSOCIATED WITH OTHER EGFR DRUGS 12377 2NIMOTUZUMAB DEMONSTRATES EFFICACY IN RANDOMIZED HEAD 26 NECK CANCER STUDY WITHOUT THE TOXICITIES ASSOCIATED WITH OTHER EGFR DRUGS 12377 3NIMOTUZUMAB DEMONSTRATES EFFICACY IN RANDOMIZED HEAD 26 NECK CANCER STUDY WITHOUT THE TOXICITIES ASSOCIATED WITH OTHER EGFR DRUGS 12377 4NIMOTUZUMAB DEMONSTRATES EFFICACY IN RANDOMIZED HEAD 26 NECK CANCER STUDY WITHOUT THE TOXICITIES ASSOCIATED WITH OTHER EGFR DRUGS 12377 5NIMOTUZUMAB DEMONSTRATES EFFICACY IN RANDOMIZED HEAD 26 NECK CANCER STUDY WITHOUT THE TOXICITIES ASSOCIATED WITH OTHER EGFR DRUGS 12377 6NIMOTUZUMAB DEMONSTRATES EFFICACY IN RANDOMIZED HEAD 26 NECK CANCER STUDY WITHOUT THE TOXICITIES ASSOCIATED WITH OTHER EGFR DRUGS 12377 7NIMOTUZUMAB DEMONSTRATES EFFICACY IN RANDOMIZED HEAD 26 NECK CANCER STUDY WITHOUT THE TOXICITIES ASSOCIATED WITH OTHER EGFR DRUGS 12377 8Religious devotion does not impact abortion decisions of young unwed women 47440 1Religious devotion does not impact abortion decisions of young unwed women 47440 2Back to normal 3A Surgery improves outcomes for spine patients 47438 1Back to normal 3A Surgery improves outcomes for spine patients 47438 2
...lowered blood pressure and signs of,heart muscle d...NN ARBOR, Mich., Oct. 29 Could eating,grapes help...? And could,grapes calm other factors that are als... A new University of Michigan Cardiovascular Cente... the October issue of the Journal of,Gerontology: ...
...2008 ICAAC/IDSA Joint Meeting, ROCKVILLE, Md., Oc...eutical company focused on commercializing,product...al, announces the,successful demonstration of syne...bitory concentration (MIC) resulting from in vitro...idate, SQ109, and Tibotec,s lead TB,drug candidate...
Other Medicine Technology:Grapes May Aid a Bunch of Heart Risk Factors, U-M Animal Study Finds 2Grapes May Aid a Bunch of Heart Risk Factors, U-M Animal Study Finds 3Grapes May Aid a Bunch of Heart Risk Factors, U-M Animal Study Finds 4Grapes May Aid a Bunch of Heart Risk Factors, U-M Animal Study Finds 5Sequella Presents Data on Synergy Between Investigational New TB Drugs SQ109 and TMC207 2
(Date:11/26/2009)...ring drug tetrathiomolybdate (TM) has been shown i...on disease, a disease caused by an overload of cop...known. Very little, however, is known about how th...dy led by Northwestern University researchers now ...onal structure of TM bound to copper-loaded metall...
(Date:11/26/2009)...ill when on an emotional rollercoaster, study find... -- Call it the fear factor meets the jubilant spo... -- especially those who root for the winning team...ely contested match and victory was in doubt, prod...w on that this Thanksgiving weekend as you,re glue...
(Date:11/26/2009)... Dr. David Kim of the Live Life Again Center, ... , is one of a growing number of physicians who ar...ites to connect with individuals who are intereste...d obesity. Dr. Kim is utilizing Facebook to share ...practice with the community. , ...
(Date:11/26/2009)... Benton Communications announces a highly effe...r retailers struggling to make an economic recover... 2009 -- Flu fears is the type of challenge that c...om, according to Dr. David Benton, business growth...growth system – The Rfactor Intensive . &...
(Date:11/25/2009)...ov.25/PRNewswire-USNewswire/--Whenmostpeoplehearth...orcanalsogivepatientsthehelptheyneed.TMJstandsfort...dible)contacts/connectswithyourskull(temporalbone)...unctionarepainwithchewing,clickingorpoppingoftheja...nincluding:headaches,fatigue,sleepdisturbances,irr...
Breaking Medicine News(10 mins):Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3Health News:Pharmacist Injects Cure for Ailing Businesses 2
..., SENSE OF URGENCY ABOUT HIV/AIDS EPIDEMIC ABROAD ...public supports maintaining (39%) or increasing (2...eveloping countries, while fewer than a quarter (2...s U.S. global health and development assistance. ...
... treatment at all, study shows , , THURSDA...e is essential for reducing the risk of heart dise...a matter of debate. , Now, two new analyses attemp...s (ARBs), probably because there aren,t enough stu...
...ay 7, 2009Approximately 6.3 million adultsor one f...itusare unaware they have the disease, and this un... billion in health care costs each year, according...he article is available free online at www.lieber...
...llinois at Chicago has received nearly $1 million ...lopment to study the benefits of green healthy hou...e American Recovery and Reinvestment Act of 2009. ... affordable, healthy housing. , At a time when th...
...Compounded Medication Program , , GLEN BURNIE, M...practice-to-home delivery veterinary pharmacy toda...y of more than 1,200 pet owners from across the U....lso indicated a very strong preference for orderin...
... Calif., May 7 PARI Pharma GmbH received an Orpha...n based on a positive recommendation by the EMEA f...tomized Investigational eFlow Nebulizer System. T...nhaled cyclosporine delivered via an eFlow Technol...
Other Medicine News:Health News:Americans Say Maintain or Increase Funding for Global Health and Development, But Take Care of Problems at Home First in the Recession 2Health News:Americans Say Maintain or Increase Funding for Global Health and Development, But Take Care of Problems at Home First in the Recession 3Health News:Americans Say Maintain or Increase Funding for Global Health and Development, But Take Care of Problems at Home First in the Recession 4Health News:Americans Say Maintain or Increase Funding for Global Health and Development, But Take Care of Problems at Home First in the Recession 5Health News:Americans Say Maintain or Increase Funding for Global Health and Development, But Take Care of Problems at Home First in the Recession 6Health News:All Blood Pressure Drugs Lower Risk of Heart Attack and Stroke 2Health News:All Blood Pressure Drugs Lower Risk of Heart Attack and Stroke 3Health News:UIC receives $1M HUD grant to study green healthy housing 2Health News:VetCentric Releases Findings of Pet Owner Survey 2Health News:PARI Pharma Receives 2nd ODD From EMEA; Moves Inhaled Tobramycin - eFlow Technology Program Forward 2Health News:PARI Pharma Receives 2nd ODD From EMEA; Moves Inhaled Tobramycin - eFlow Technology Program Forward 3Health News:PARI Pharma Receives 2nd ODD From EMEA; Moves Inhaled Tobramycin - eFlow Technology Program Forward 4
...agement software enables you to automate your pipe... Pipette Tracker to create a schedule for pipette ...tolerances and immediately see Pass/Fail status an... Pipette Tracker enables increased efficiency and ...
... pump is about the size of a C battery. Within its..., a rotor supported by two ceramic bearings, and a...peller that pumps blood from the heart at up to 7 ...iological heart, the Jarvik 2000 augments the weak...
...an innovative, safe and effective surgical approac... in men following prostatectomy. It also is a solu...ial urinary sphincter due to limited manual dexter...., ,InVance uses a mesh sling, anchored with s...
...tion cardiac assist system primarily designed as a...tients suffering heart failure., ,It is a bloo...diseased heart to help the ailing hearts pumping f...f life. , ,It can also be used as a bridge to ...
Medicine Products: